Notably, our research demonstrates that elevated GDF-15 levels are closely associated with an increased risk of metabolic complications and heightened inflammation in individuals affected by both obesity and diabetes. Here, GDF15 is linked to obesity due to melanocortin 4 receptor deficiency.